Maravai LifeSciences Holdings IncNASDAQ:MRVI
- LAST PRICE5.0100
- TODAY'S CHANGE (%)-0.2800 (-5.2930%)
- Bid / Lots5.0000/ 6
- Ask / Lots5.0100/ 1
- Open / Previous Close5.2500 / 5.2900
- Day Range
- 52 Week Range
- Volume201,258
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MRVI |
|---|---|---|
| 09:32 ET | 12600 | 5.2 |
| 09:33 ET | 6108 | 5.14 |
| 09:35 ET | 2200 | 5.1 |
| 09:37 ET | 9404 | 5.08 |
| 09:39 ET | 7189 | 5.04 |
| 09:42 ET | 20460 | 5.04 |
| 09:44 ET | 20010 | 4.98 |
| 09:46 ET | 1762 | 5 |
| 09:48 ET | 36728 | 4.9701 |
| 09:50 ET | 26774 | 5.02 |
| 09:51 ET | 4102 | 5.005 |
| 09:53 ET | 1423 | 5.01 |
| 09:55 ET | 3172 | 5.09 |
| 09:57 ET | 2496 | 5.06 |
| 10:00 ET | 1817 | 5.0899 |
| 10:02 ET | 1700 | 5.02 |
| 10:04 ET | 2059 | 5.02 |
| 10:06 ET | 4600 | 5.01 |
| 10:08 ET | 2390 | 5 |
| 10:09 ET | 3620 | 5.01 |
| 10:11 ET | 7810 | 5.0066 |
| 10:13 ET | 1300 | 5.01 |
Nov 14, 2024
DJ Maravai LifeSciences Initiated at Peer Perform by Wolfe Research, from 8:52AM ET on Thursday Nov 14, 2024 by Dow Jones
8:52AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 12, 2024
Maravai LifeSciences Announces November 2024 Investor Conference Schedule, from 8:05AM ET on Tuesday Nov 12, 2024 by Dow Jones
8:05AM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 8, 2024
DJ Maravai LifeSciences Shares Plunge 39% After Guidance Cut, 3Q Miss, from 2:58PM ET on Friday Nov 08, 2024 by Dow Jones
2:58PM ET on Friday Nov 08, 2024 by Dow JonesDJ Maravai LifeSciences Is Maintained at Outperform by RBC Capital, from 12:57PM ET on Friday Nov 08, 2024 by Dow Jones
12:57PM ET on Friday Nov 08, 2024 by Dow JonesDJ Maravai LifeSciences Cut to Market Perform From Outperform by William Blair, from 8:21AM ET on Friday Nov 08, 2024 by Dow Jones
8:21AM ET on Friday Nov 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Maravai LifeSciences Holdings Inc | 1.3B | -3.0x | --- |
CareDx Inc | 1.2B | -8.8x | --- |
MiMedx Group Inc | 1.4B | 18.3x | --- |
BioCryst Pharmaceuticals Inc | 1.6B | -11.9x | --- |
Dynavax Technologies Corp | 1.6B | 102.5x | --- |
Galapagos NV | 1.8B | -28.4x | --- |
Company Information
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enable the development of drug therapies, diagnostics and vaccines and to support research on human diseases. Its companies provide products and services in the fields of nucleic acid synthesis and biologics safety testing to various biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. The Company operates through two segments. Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acid products to support the needs of customer research, therapeutic and vaccine programs. The segment also provides research products for labeling and detecting proteins in cells and tissue samples. Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities.
Contact Information
- Headquarters
- 10770 Wateridge Circle Suite 200 Suite 200SAN DIEGO, CA, United States 92121
- Phone
- 858-546-0004
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Carl Hull
- Chief Executive Officer, Director
- William Martin
- Chief Financial Officer
- Kevin Herde
- President - Nucleic Acid Production
- Andrew Burch
- Executive Vice President, Chief Commercial Officer
- Rebecca Buzzeo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3B |
|---|---|
Revenue (TTM) | $276.9M |
Shares Outstanding | 252.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.08 |
EPS | $-1.65 |
Book Value | $1.66 |
P/E Ratio | -3.0x |
Price/Sales (TTM) | 4.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -73.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
